The University of Edinburgh

MiChro is an innovative app that empowers users to achieve optimal health. By leveraging cutting-edge principles of chronobiology, MiChro provides personalized recommendations tailored to each user’s health conditions, lifestyle, and goals. Our app integrates advanced data analytics and machine learning to continuously evolve, delivering actionable insights into nutritional status and dietary habits. This ensures users can make sustainable, long-term improvements to their health while enjoying a seamless, engaging experience. Current nutrition apps often fail to deliver the personalization users need. They rely on tedious manual entry, overlook individual restrictions and preferences, and lack interactivity—leading to poor user retention and limited impact. MiChro revolutionizes the nutrition app experience with its intuitive design, personalized features, and dynamic engagement, ensuring every user feels supported on their health journey. Join us in redefining health empowerment through personalized nutrition and advanced technology. Key words: Personalized Nutrition, Chronobiology, HealthTech, AI-powered Health, Nutritional Optimization, Machine Learning for Health, Health Empowerment, Lifestyle Medicine

Lentitek is a cell and gene therapy company developing gene therapies and gene-modified cell therapies to broaden access to cures. It focuses on increasing the production yields of lentiviral vectors through its platform, using a novel promoter and proprietary production methods. The approach aims to deliver substantially higher yields, potentially reducing manufacturing costs and improving scalability for healthcare providers delivering gene therapies.

The National Biofilms Innovation Centre (NBIC) serves as a collaborative hub uniting academia, industry, government, and public policy to address the challenges posed by biofilms, which significantly impact global economic activity across sectors such as food, health, shipping, clean water, and energy. Supported by funding from the BBSRC, Innovate UK, and Hartree Centre, NBIC's mission focuses on fostering a network for research and innovation that catalyzes partnerships with industry to drive breakthrough innovations. The Centre facilitates the exploration of unmet needs and the exchange of ideas through various initiatives, including roadmaps, workshops, and conferences. Additionally, NBIC is dedicated to nurturing the next generation of scientists through PhD and Post-Doc programs, alongside entrepreneurial training, aimed at enhancing their expertise and understanding of the commercial landscape while promoting the creation of new start-ups.

BioCaptiva develops innovative liquid biopsy technology devices aimed at diagnosing and monitoring hard-to-detect cancers. Its proprietary platform captures circulating free DNA from blood samples, overcoming current limitations of cancer liquid biopsy testing.

Simon Community Scotland is a charitable social firm offering home and support to the homeless people.

Mocean Energy develops technologies to harness wave power and accelerate the transition to a zero-carbon future. Based in Edinburgh, United Kingdom, the company designs an energy converter with a power take-off mechanism that converts wave kinetic energy into electricity, enabling reliable, affordable renewable power for subsea applications such as control systems, remotely operated vehicles, and autonomous underwater vehicles.

Sphere Fluidics Limited is a life sciences company focused on developing innovative technologies for single-cell analysis and characterization. The company offers unique products and collaborative research and development services that aid in the discovery of new cell strains and molecules. Its cell analysis systems facilitate the screening and isolation of rare and valuable biological variants, catering to various applications in research, therapeutic development, bioproduction, and diagnostics. By streamlining these processes, Sphere Fluidics enables clients to reduce costs and time, thereby accelerating advancements in biological and biopharmaceutical discovery.